Does anyone think there will be a buyout?
No reason for a buyout at this point. Still to much risk vs reward for big pharma to acquire. However, the drug application acceptance, regardless of priority, is still a step in the right direction. The important thing here is the action date as mentioned by the FDA by Sept 4 which will really decide if it moves forward from here.